• First Biosimilar Rituximab for Lymphoma Approved in US

    5 monthes ago - By Medscape

    Truxima, designed for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin lymphoma, can be used as a single agent or in combination with chemotherapy.
    FDA Approvals
    Read more ...


  • FDA Approves Rituximab Biosimilar for NHL

    5 monthes ago - By MedPageToday

    Indications for front line or beyond, single agent or combination
    Read more ...